Progyny's Q1 2024 revenue increased by 7.6% to $278.1 million, driven by growth in clients and covered lives. Net income was $16.9 million, or $0.17 per diluted share. The company repurchased 723,577 shares for $26.4 million during the quarter.
Revenue increased by 7.6% year-over-year to $278.1 million.
Net income was $16.9 million, or $0.17 per diluted share.
Adjusted EBITDA increased by 8% year-over-year to $50.3 million.
The company had 451 clients as of March 31, 2024, compared to 379 clients as of March 31, 2023.
The Company is providing the following financial guidance for the full year ending December 31, 2024 and the three-month period ending June 30, 2024:
Visualization of income flow from segment revenue to net income